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Abstract
Post-translational modification with the Small Ubiquitin-like Modifier (SUMO) is conserved
in eukaryotic organisms and plays important regulatory roles in proteins affecting diverse
cellular processes. In Trypanosoma brucei, member of one of the earliest branches in
eukaryotic evolution, SUMO is essential for normal cell cycle progression and is likely to be
involved in the epigenetic control of genes crucial for parasite survival, such as those
encoding the variant surface glycoproteins. Molecular pathways modulated by SUMO have
started to be discovered by proteomic studies; however, characterization of functional con-
sequences is limited to a reduced number of targets. Here we present a bacterial strain
engineered to produce SUMOylated proteins, by transferring SUMO from T. brucei together
with the enzymes essential for its activation and conjugation. Due to the lack of background
in E. coli, this system is useful to express and identify SUMOylated proteins directly in cell
lysates by immunoblotting, and SUMOylated targets can be eventually purified for biochem-
ical or structural studies. We applied this strategy to describe the ability of TbSUMO to form
chains in vitro and to detect SUMOylation of a model substrate, PCNA both from Saccharo-
myces cerevisiae and from T. brucei. To further validate targets, we applied an in vitro
deconjugation assay using the T. brucei SUMO-specific protease capable to revert the pat-
tern of modification. This system represents a valuable tool for target validation, mutant gen-
eration and functional studies of SUMOylated proteins in trypanosomatids.
Introduction
SUMOylation is a post-translational modification that involves the covalent conjugation of the
Small Ubiquitin-like Modifier (SUMO) to a diverse number of target proteins. The functional
consequences of SUMOmodification are various, typically involving alterations in subcellular
localization, stability, activity or protein-protein interactions of the modified substrates [1,2].
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SUMOs are ~12 kDa proteins that belong to the Ubiquitin-like proteins (UbLs) family.
Although SUMO shares low amino acid sequence identity with ubiquitin (Ub) (~20%), these
proteins present an almost identical structural fold with exception of an unstructured N-termi-
nal extension that is present in SUMO and absent in other UbLs and Ub itself [3].
SUMO proteins are conserved and ubiquitously expressed in eukaryotes, but absent in pro-
karyotes and archaea. Generally, lower eukaryotes such as yeast or invertebrates have a single
SUMO gene, while in vertebrates and plants different SUMO paralogs are expressed. Some
SUMO isoforms, such as SMT3 in yeast and SUMO 2/3 in vertebrates, can polymerize and
form polySUMO chains in vivo and in vitro usually via Lys residues that conform a SUMOyla-
tion consensus motif and are often found at the N-terminal region [4,5].
SUMOylation occurs via a conjugation pathway analogous to ubiquitylation which involves
a three step enzymatic cascade. Initially SUMO is synthesized as an inactive precursor that
must be processed by specific proteases in order to expose the C terminal di-glycine motif, nec-
essary for conjugation. The mature form of SUMO is then activated in an ATP dependent reac-
tion by a SUMO specific E1 activating enzyme (heterodimer E1a/E1b) [6] and a thioester bond
is formed between the terminal glycine residue and the catalytic cysteine residue of E1b sub-
unit. SUMO is then transferred by transesterification to a cysteine residue of a single E2 conju-
gating enzyme (Ubc9). Contrary to ubiquitin-specific E2 enzymes, Ubc9 can directly interact
with SUMO substrates by recognizing SUMOylation consensus motifs and catalyze the forma-
tion of an isopeptide bond between SUMO C-terminal glycine residue and the ε-amino group
of an acceptor lysine in the target protein [7]. Due to this peculiarity E1 and E2 enzymes are
sufficient for in vitro SUMO attachment [8]. Nevertheless, the conjugation process can be assis-
ted by SUMO E3 ligases which usually promote the interaction of E2-SUMO with the substrate
or act by positioning SUMO in a conformation that facilitates its transfer to the target lysine
residue [9]. Thus SUMO conjugation is generally increased in the presence of E3 ligases in vivo
and in vitro.
This post-translational modification can be reverted by SUMO proteases that cleave the iso-
peptide bond between SUMO and its substrate; some of them are at the same time responsible
for SUMOmaturation. Currently all the SUMO specific proteases identified are cysteine prote-
ases that can be classified in three classes: Ulp/SENP [10] proteases, Desi proteases [11] and
USPL1 protease [12]. The Ulp/SENP family is the most studied group up to date and shows the
broadest substrate specificity. These enzymes possess a conserved C-terminal domain (C48)
which presents the catalytic triad His-Asp-Cys. In yeast only two deSUMOylating proteases
have been identified (Ulp1 and Ulp2) and both of them belong to this class. In mammals six
proteases belonging to this class are found, four of them (SENP-1, SENP-2, SENP-3 y SENP-5)
present similarity with Ulp1 while the other two (SENP-6 and SENP-7) are more closely related
to Ulp2. All Ulp/SENP enzymes possess isopeptidase activity being able to remove SUMO
from substrates although they have different substrate specificity and play different roles in the
SUMOylation pathway. Ulp1 and its homologues are C-terminal hydrolases that carry out
SUMO precursor processing; while Ulp2, SENP-6 and SENP-7 are the main enzymes responsi-
ble for polySUMO chain edition [13].
Trypanosomatids are parasitic protists that cause serious neglected diseases to man, affect-
ing a high number of people worldwide; Trypanosoma cruzi is the causative agent of Chagas
disease in South America while Trypanosoma brucei is the ethiological agent of African sleep-
ing sickness. Like in other invertebrates, a single SUMO gene has been identified in these
parasites.
T. brucei SUMO (TbSUMO) shares 33% and 37% similarity with yeast SUMO (Smt3) and
human SUMO-1 [14]. Like this latter isoform TbSUMO does not contain internal SUMOyla-
tion consensus sites and it is still unknown whether it is able to form SUMO chains. The 3D
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structure of TbSUMO has been solved by NMR, showing that TbSUMO structure is highly
similar to all other SUMOs and it is able to interact with human Ubc9 in a unique way through
a Thr residue (T30) in the N-terminal extension [14]. By performing RNAi experiments it
could be determined that TbSUMO is an essential protein for both replicative life-cycle stages
of the parasite, procyclic (PCF) and bloodstream (BSF) forms. In PCF parasites SUMO absence
inhibits mitosis, arresting cells in G2/M phase and affects chromosome segregation [15], while
in SUMO deficient BSF parasites inhibition of cytokinesis could be observed [16]. Notably, in
contrast to other eukaryotic organisms Trypanosomes contain a limited number of general
transcription factors what suggests lack of regulation at transcriptional level. In this way post-
transcriptional and post-translational modifications, including SUMOylation, may play funda-
mental roles in regulation of gene expression and coordination of diverse cellular processes
necessary for parasite differentiation and survival. In T. brucei SUMO has been associated to
regulation of antigenic variation of the parasite surface glycoprotein coat, a process where the
major surface antigenic protein is replaced by a different variant with certain frequency, pro-
tecting the parasite from the host immune response. SUMO was found to be enriched in a par-
ticular region of the nucleus of BSF parasites together with the E3 ligase Siz1 and the RNApolI,
specifically at the chromatin region that is actively transcribing the variant surface glycoprotein
suggesting that SUMOylated unknown factors are involved in VSG mono allelic active expres-
sion [17].
In spite of its importance, only four trypanosomatid proteins have been experimentally
demonstrated to be SUMOylated so far: TcMCA3 [18] and PAR2 [19] in T. cruzi, and Aurora
kinase B [20] and RPA1 in T. brucei [17]. Usually, identification of proteins modified by
SUMO is performed by high-throughput proteome analysis by mass spectrometry, but in vitro
assays are often necessary for the study and validation of the actual SUMOylation of specific
substrates. For this reason, the development of a specific SUMOylation system is a fundamen-
tal tool for the study of this post-translational modification. In the present work, we have suc-
ceeded in confirming the activity and conjugation ability of the enzymes TbE1 and TbE2, and
in developing a specific system for the validation of SUMOylated proteins in T. brucei, by com-
bining the reconstitution of the SUMOylation machinery of this parasite in Escherichia coli
with in vitro deconjugation assays.
Results
Reconstitution of the T. brucei SUMOylation machinery in E. coli
To promote the recombinant expression of T. brucei SUMOylated proteins in bacteria, we
decided to transfer the complete set of enzymes essential for this post translational modifica-
tion in this organism to E. coli. Fig 1A illustrates the triple vector system, with compatible ori-
gins of replication and independent antibiotic selection, designed to inducibly co-express both
subunits of the SUMO activating enzyme (TbE1a and TbE1b) from the Duet vector pACYC-
Duet-1, together with processed SUMO (TbSUMO) and its conjugating enzyme (TbE2) from
other Duet vector pCDFDuet-1 and lastly, the target of SUMOylation from vector pET28.
We started evaluating the correct expression and solubility of the individual components in
bacterial lysates by SDS-PAGE followed by Coomassie Blue staining. As shown in Fig 1B, we
observed that TbSUMO and the conjugating enzyme were highly expressed in E. coli, while the
activating enzyme subunits, and in particular TbE1b, were produced at significantly lower lev-
els [21]. Recombinant expression was further confirmed for the proteins expressed as N-termi-
nal fusions to either His tag (TbE1a and TbE2) or HA epitope (TbSUMO) by Western blot
analysis using commercially available antibodies (Fig 1C). All recombinant proteins migrated
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Fig 1. Reconstitution of the T. brucei SUMOylation system in E. coli. (A) Schematic representation of the plasmids used to express the multiple
components of the T. brucei SUMOylation system in bacteria. pACYCDuet-1 carrying the P15A replicon and chloramphenicol resistance gene (cat) was
designed to direct the co-expression of T. brucei activating enzyme subunits a and b (TbE1a and TbE1b) as fusions to an N-terminal His-tag or a C-terminal
S-tag, respectively. pCDFDuet-1 carries the CloDF13 replicon and the streptomycin/spectinomycin resistance gene (aadA) and drives the co-expression of
mature SUMO (TbSUMO) and its conjugating enzyme (TbE2) both tagged at the N-terminus either with an HA epitope or a His tag, respectively. Finally,
pET28 carries the ColE1 origin of replication and the kanamycin resistance gene (Kmr) and is used for individual expression of SUMOylation target proteins.
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as single bands at the expected molecular weight with the exception of SUMO, for which an
anomalous electrophoretic behavior has already been described [22].
We next assessed the performance of the system in the absence of a SUMO target. Western
blot analysis using anti-HA (Fig 2A) or anti-TbSUMO (S1 Fig) antibodies of the TbSUMO
pattern of cells transformed just with plasmid pCDFDuet-1-TbSUMO-TbE2 showed that
TbSUMO was present as a single band; however, when the two plasmids (pCDFDuet-1-
TbSUMO-TbE2 and pACYCDuet-1-TbE1a-TbE1b) were used to transform E. coli, additional
slowly migrating bands likely corresponding to TbSUMOmultimers were detected. It has been
previously reported that SUMO from T. cruzi possess two internal SUMOylation sites that can
(B) Analysis of recombinant protein expression by Coomassie Blue staining of SDS-PAGE gels. Equal amount of protein (30 μg) was loaded in each lane.
Samples correspond to the soluble fraction of E. coli BL21 (DE3) host cells transformed with the empty vector pACYCDuet-1 (lanes 1 and 2),pACYCDuet-1-
TbE1a-TbE1b (lane 3 and 4), pCDFDuet-1 (lane 5 and 6), pCDFDuet-1-TbSUMO-TbE2 (lane 7 and 8), or with the complete SUMOylation system (lane 9)
and induced (I) or not (UI) for protein expression during 5 hr at 37°C using 1mM IPTG. The predicted molecular masses of the recombinant proteins (including
tags) are: 14 kDa for TbSUMO, 28 kDa for TbE2, 40 kDa for TbE1a and 97 kDa for TbE1b. Recombinant proteins are marked with an asterisk in the figure
and labeled with an arrowhead at the right of the gel. (C) Immunoblot detection of the recombinant proteins was performed on the same samples using anti-
HA antibodies for TbSUMO and anti-His antibodies for TbE2 and TbE1a.
doi:10.1371/journal.pone.0134950.g001
Fig 2. TbSUMO chain formation. (A) Anti-HAWestern blot analysis of soluble cell extracts from induced cultures of E. coli transformed with only one
plasmid pCDFDuet-1-TbSUMO-TbE2; pACYCDuet-1-TbE1a-TbE1b or both pCDFDuet-1-TbSUMO-TbE2 and pACYCDuet-1-TbE1a-TbE1b. Different
exposure times were used to evidence the SUMO ladder which was observed at the shorter times while a more complex pattern was obtained with longer
periods of exposure. TbSUMOmonomer, dimers, trimers and multimers are indicated. (B)Western blot analysis of SUMO pattern performed on soluble cell
extracts from an incomplete (lanes 1 and 2) or a complete bacterial SUMOylation system (lane 3) using a Lys deficient version of SUMO (TbSUMOK9R).
Note the complete absence of SUMO conjugates implying the absence or artificial SUMOylation of bacterial proteins.
doi:10.1371/journal.pone.0134950.g002
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be modified by human SUMO-1 in E. coli, one of them possibly located in a typical consensus
motif while the other occurring in a yet non-identified Lys residue [19]. To discriminate if
SUMO chain formation could also take place in T. brucei, we replaced the wild-type TbSUMO
in our bacterial assay with a Lys deficient version of the protein (in which all Lys residues were
mutated to Arg and therefore cannot be substrate for SUMOylation) and performed a similar
Western blot analysis. As shown in Fig 2B, the majority of the higher molecular weight proteins
were now undetectable confirming that they indeed correspond to polySUMO chains.
In vivo heterologous SUMOylation of a model substrate using T. brucei
system
We validated the functionality of the "in bacteria" T. brucei SUMOylation system introducing
the third vector which directs the expression of a well-established target of SUMO, the prolifer-
ating cell nuclear antigen (PCNA) from Saccharomyces cerevisiae (see below) and from T.
brucei (S3 Fig), fused to a triflag epitope at the C-terminus. Protein expression was induced
with 1 mM IPTG at 37°C for 5 hr, and cell lysates were analyzed by Western blot using anti-
Flag antibodies. ScPCNA can be obtained with high yield and appears as a single band with the
expected size when expressed alone in E. coli (Fig 3A, lane 1). However, when co-expressed
with TbSUMO, TbE1a/TbE1b and TbE2 enzymes, two additional slower-migrating bands can
be detected (Fig 3A, lane 4). These bands were not visible when ScPCNA was co-expressed
with the partially reconstituted system, which were used as negative controls (Fig 3A, lane 2
and 3). Additional controls are shown in S2 Fig.
The SUMOylation pattern of ScPCNA has been extensively studied [23]. Two lysine resi-
dues were unambiguously identified as SUMO targets (K127 and K164), while some other/s
lysine residue/s seem also to be modified by SUMO but were not identified by mutational anal-
ysis to date. To compare our SUMOylation pattern with these observations we independently
mutated the K127 or K164 to arginine, and analyzed the changes in the ScPCNA pattern by
Western blot analysis using anti-Flag antibodies. As shown in Fig 3B, the wild type and the
mutant versions were expressed correctly when transformed individually in BL21 (DE3) cells.
When the K127R mutant was transformed together with the complete SUMOylation system
we observed that the upper band of the triplet around 55 kDa disappeared suggesting that
this band can be attributed to the modification of this residue. On the other hand, the triplet
was again visible when analyzing the K164R mutant transformed together with the complete
SUMOylation system, suggesting that this residue is not responsible for any of these bands.
However, a clearly decrease in the intensity of the higher molecular weight bands (~100 kDa)
was observed for these mutants likely suggesting that this band could correspond to multi or
poli-SUMOylation of PCNA both in K127 and in K164.
To demonstrate that ScPCNA is actually being SUMOylated we repeated the experiment
using a different TbSUMO construct. We employed a His-HA-tagged TbSUMO variant that
allows purification of SUMOylated PCNA using Ni2+ affinity chromatography and immuno-
blot detection of the SUMOylated protein using anti-Flag antibodies. As shown in Fig 3C and
3D the same doublet is reactive with both anti-Flag and anti-HA antibodies confirming that
they certainly correspond to SUMO covalently linked to PCNA.
Production of recombinant TbSENP: evaluation of peptidase and
isopeptidase activities
To add confidence to our bacterial SUMOylation assay, we decided to specifically revert this
modification using a recombinant SUMO specific deconjugating enzyme from T. brucei. To
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Fig 3. In-bacteria SUMOylation of ScPCNA. (A) Anti-FlagWestern blot analysis of ScPCNA performed on soluble cell extracts from induced cultures of E.
coli transformed with pET28-ScPCNA-3xFlag alone (lane 1) or in the background of an incomplete (lane 2, pACYCDuet-1-TbE1a-TbE1b; lane 3, pCDFDuet-
1-TbSUMO-TbE2) or a complete (lane 4, pCDFDuet-1-TbSUMO-TbE2 plus pACYCDuet-1-TbE1a-TbE1b) SUMOylation system. (B)Mutational analysis of
ScPCNAwas performed in a background of E. coli Bl21 (DE3) cells (C) or in a complete SUMOylation system (S). The band corresponding to SUMO
conjugated to K127 and the higher molecular weight band corresponding to poliSUMOylated PCNA at K127 or K164 are marked with asterisks. (C) Bacterial
lysate overexpressing SUMOylated ScPCNA or the complete SUMOylation system as a control, were subjected to Ni+2 affinity chromatography. The inputs
(lane 1 and 3) and the eluates (lane 2 and 4) were analyzed by Coomassie staining or immunoblotting using monoclonal anti-Flag antibodies.
doi:10.1371/journal.pone.0134950.g003
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develop this tool we cloned, expressed and purified TbSENP in E. coli C-terminally fused to
glutathione S-transferase (GST) (Fig 4A).
We first tested the ability of this peptidase to cleave a double-tagged TbSUMO precursor
containing an N-terminal HA epitope and a C-terminal GST. HA-TbSUMO-GST was incu-
bated with TbSENP at 37°C for 1 hr and the reaction products were analyzed by Western blot
using anti-HA antibodies (Fig 4B) and anti-GST antibodies (S4 Fig). Fig 4B shows that
TbSENP cleaves the TbSUMO precursor resulting in a cleavage product of about 25 kDa, com-
patible with proteolytic processing taking place after the diGly motif. The cleavage was inhib-
ited in the presence of a general inhibitor of cysteine peptidases, iodoacetamide (NEM).
We next assessed the ability of TbSENP to deconjugate TbSUMO from a broad spectrum of
substrates. We used a transgenic cell line of procyclic parasites in which the endogenous
TbSUMO locus was replaced with a His-HA tagged gene allowing efficient purification of
TbSUMO conjugates by nickel affinity chromatography. We mixed purified TbSUMO targets
with TbSENP and incubated the reaction for 1 hr at 37°C. Western blot analysis of the samples
using anti-HA antibodies showed an increase of free TbSUMO protein intensity in parallel
with a marked reduction of TbSUMO conjugates that was not observed when NEM was added
to the reaction mixtures (Fig 4C).
Fig 4. TbSENP peptidase and isopeptidase activity. (A) SDS-PAGE followed by Coomassie Blue staining (left panel) or Western blot analysis using anti-
GST antibodies of TbSENP purification (right panel). In: input, cell-free extract from bacteria overexpressing TbSENP, FT: Flow through, fraction not retained
by the resin and El: eluate, sample retained and eluted from the resin. The full length protein is marked with an arrowhead. Faster migrating bands likely
correspond to TbSENP-GST degradation products. (B) SUMO precursor cleavage by TbSENP was evaluated in vitro using a TbSUMO precursor produced
in E. coli tagged at the N-terminus with His-HA and fused at the C-terminus to the GST protein. After purification on glutathione-agarose resin 7.5 μg of His-
HA-TbSUMO-GST protein was mixed with 0.75 μg of purified recombinant TbSENP (produced as described in Materials and Methods) in 30 μl of TBS
containing 1 mMDTT in the absence (lane 2) or presence (lane 3) of the general cysteine peptidase inhibitor N-ethylmaleimide 20 mM final concentration
(NEM) and incubated at 37°C for 1 hr. Samples were analyzed byWestern blot using anti-HA monoclonal antibodies. The substrate without the addition of
the protease was run as a control (lane 1). (C) Broad-specificity SUMO deconjugation ability of TbSENP was analyzed on purified HA-tagged TbSUMO
conjugates from parasites (See Materials and Methods). Isopeptidase activity was evaluated in reaction mixtures containing 3 μg of TbSUMO conjugates
and 0.75 μg of purified TbSENP in 30 μl of TBS containing 1 mMDTT in the presence (lane 2) or in the absence (lane 3) of 20 mM NEM incubated at 37°C for
1 hr. Samples were analyzed byWestern blot using anti-HA monoclonal antibodies. The substrates without the addition of the protease was run as a control
(lane 1).
doi:10.1371/journal.pone.0134950.g004
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Altogether these results demonstrate that TbSENP is an active cysteine peptidase that, as
described for its yeast and mammalian orthologues [10,24,25,26,27], is able both to process
TbSUMO precursor (peptidase activity) and to deconjugate TbSUMO from its various targets
(isopeptidase activity).
Target validation using bacterial SUMOylation assay coupled to in vitro
deSUMOylation using T. brucei components
We finally demonstrated the function of TbSENP in confirming a substrate of SUMOylation.
As shown in Fig 5, the two additional slowly migrating bands observed when ScPCNA was co-
expressed with the T. brucei SUMOylation system in bacteria completely disappeared upon
treatment of cell lysates with TbSENP, confirming that they indeed correspond to SUMOylated
ScPCNA proteins. Thus, combining bacterial SUMOylation assays with in vitro deconjugation
reactions represents a suitable strategy to validate SUMO targets.
Discussion
We have succeeded in establishing a recombinant system to produce SUMOylated proteins
in bacteria by transferring the minimal set of enzymes needed for this modification in T. brucei
to E. coli. We co-expressed both activating enzyme subunits together with the conjugating
enzyme and processed TbSUMO (already exposing the diGly motif) using two different Duet
vectors, while a compatible pET28 vector was used to express the target protein of interest. The
addition of an appropriate tag in the target allows the detection of the SUMOylated form by
Western blot analysis directly on cell lysates without any enrichment step. Moreover, the addi-
tion of another tag on TbSUMOmakes feasible a tandem affinity purification of the modified
target. However, tags should be chosen carefully when biochemical and/or structural studies of
the SUMOylated proteins are planned to be undertaken [28,29].
Fig 5. In vitro deconjugation of SUMOylated ScPCNA.Cell lysates of E. coli heterologously expressing
ScPCNA and the complete T. brucei SUMOylation system (lane 1) were incubated at 28°C in the absence
(lane 2) or presence of recombinant TbSENP (lane 3) as described in Material and Methods. Deconjugation
ability of TbSENP was specifically inhibited by the addition of 20 mMNEM (lane 4). Reaction mixtures were
analyzed byWestern blot using anti-Flag monoclonal antibodies.
doi:10.1371/journal.pone.0134950.g005
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This bacterial SUMOylation system is useful not only to validate the SUMOylation sites
found in proteomic experiments, but also to generate and test non-SUMOylable mutants, a
task that can be sometimes laborious due to the appearance of cryptic SUMOylation sites upon
mutation of the canonical ones [30,31,32]. We generated and evaluated the performance of a
His-HA-TbSUMO protein with a mutation of the Thr residue at position 106 (prior to the
diGly motif) to Lys (S5 Fig). This TbSUMO version is useful to map acceptor Lys in substrates
by MS/MS locating the remnant diGly after a subsequent trypsin or Lys-C digestion.
This in bacteria SUMOylation reaction is simple, fast and economically convenient when
compared to the in vitro reactions using commercially available or "in-house purified" human
or yeast recombinant enzymes [21,28,29,33,34]. Furthermore, this tool has been specifically
designed for trypanosomatid proteins and can potentially avoid subtle differences in specificity
(i.e., the Lys residue that is being modified or the ability to form chains) when using a source of
enzyme from a different organism. While this work was being revised, a paper by Ye et al.
reported the development of an in vitro system for T. brucei [35].
In this assay we chose ScPCNA as a model target, a well-known SUMOylation substrate
that has been employed also as heterologous control for other in vitro SUMOylation systems in
other organisms [36]. PCNA is a processivity factor of DNA polymerase and its SUMOylation
has been associated in vivo with genome maintenance [37]. The modification pattern observed
using this in vivo reconstituted SUMOylation system resembles the one obtained with the in
vitro reconstituted SUMOylation machinery of Saccharomyces cerevisiae [23].
With the reconstituted system, we confirmed the functionality of the TbE1 and TbE2
proteins that were annotated as putative enzymes [18,38]. We further studied another vital
component of the SUMOylation/deSUMOylation regulatory cycle, which is the SUMO specific
peptidase TbSENP. We cloned, expressed and purified the recombinant enzyme and showed
that this protein: 1) possesses the ability to process TbSUMO precursor making it available
for activation and conjugation reactions and, 2) can revert TbSUMOmodification by cleaving
off TbSUMO from its target protein through its isopeptidase activity, an ability that can be
exploited to confirm protein SUMOylation by disappearence of high molecular weight adducts
after treatment with the enzyme.
Finally, we demonstrated that TbSUMO forms multimers in our bacterial SUMOylation
assay, an observation already suggested by the in vitro reactions of its T. cruzi orthologue [19].
However, TbSUMO chain formation seems not to be an essential feature in vivo since it was
possible to replace the endogenous gene with a Lys deficient version [39], similar to the situa-
tion described for S. cerevisiae [40].
Materials and Methods
Trypanosome culture
Parasites employed were procyclic form (PCF) T. brucei brucei Lister 427 [41] andHis-HA-
TbSUMO, a Lister 427 cell line with both SUMO alleles replaced by a His-HA-TbSUMO vari-
ant [39].
PCF cell lines were maintained axenically at 28°C in SDM-79 medium [42] supplemented
with 10% (vol/vol) heat-inactivated fetal calf serum (Natocor, Córdoba, Argentina) and 7.5
mg/l hemin.
Genomic DNA purification and Polymerase Chain Reaction
T. brucei brucei Lister 427 PCF collected by centrifugation were washed twice with PBS (0.1 M
sodium phosphate, 0.15 M NaCl, pH 7.4) and genomic DNA was isolated using DNAzol
Reagent as described by the manufacturer (Life Technologies, Carlsbad, CA, USA).
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Polymerase Chain Reaction (PCR) was performed at a final volume of 50 μl containing
genomic (~300 ng) or plasmid DNA (~50 ng), 30 pmoles of the specific primers (Macrogen,
Seoul, Korea), 2.5 mM of each deoxynucleotide triphosphate (dATP, dCTP, dGTP, dTTP)
(New England Biolabs), 1.5 mMMgCl2 (Life Technologies), 0.2 UI Taq DNA polymerase (Life
Technologies) and reaction buffer as indicated by the manufacturer (Life Technologies).
For the amplification reaction a thermocycler (Mycycler, Bio-Rad, Hercules, CA, USA) was
employed: an initial denaturation step at 94°C for 10 min was followed by 35 cycles of a) dena-
turation at 94°C 1 min, b) hybridization at 55°C 1 min, c) elongation at 72°C -1 min per kb of
DNA amplified; the final elongation step was performed at 72°C for 10 min.
Plasmid constructions
The open reading frames (ORFs) of TbSUMO (Tb927.5.3210), TbE2 (Tb927.2.2460), TbE1a
(Tb427tmp.02.5410), TbE1b (Tb927.5.3430) and TbPCNA (Tb927.9.5190) were amplified by
PCR from T.brucei genomic DNA using the following primers: HA-TbSUMO sense CATATG
TACCCATACGATGTTCCAGATTACGCTATGGACGAACCCACTCATAAC, TbSUMO
antisense CTCGAGTCACCCGCCTGTCTGCTCCACC, TbE2 sense GGATCCGATGTCCGG
GCTATCTTTAGC, TbE2 antisense GCGGCCGCTTATACCCGCTTCCGGTG, TbE1a sense
GAATTCGATGAATGCGGACGAAAAAACG, TbE1a anti sense AAGCTTCTACGGGTTG
CGCAGGTGCC, TbE1b sense CATATGCACGTTAATGTCGGACATATTGTC, TbE1b anti-
sense CTCGAGATCAATTTCTACAACCTCGTCACTATC, TbPCNA sense CCATGGCCC
TTGAGGCTCAGGTTCTGCAC and TbPCNA antisense CCATGGACTCGGCGTCGTCCA
CCTTTG.
To generate HisHA-TbSUMO variants we used plasmid constructions with the complete
ORF of HisHA-TbSUMO or HisHA-TbSUMO ORF with all Lys residues replaced by Arg
(GenScript, Piscataway, NJ, USA) as template for PCR amplification using the following prim-
ers: HisHA-TbSUMO sense CATATGGACGAACACCACCAC, TbSUMO antisense CTCGA
GTCACCCGCCTGTCTGCTC (HisHA-TbSUMO variant), HisHA-TbSUMO sense CATAT
GGACGAACACCACCAC, TbSUMOK9R antisense CTCGAGTCACCCGCCCGGCTGCTC
(HisHA-TbSUMOK9R variant), HisHA-TbSUMO sense CATATGGACGAACACCACCAC,
TbSUMOT106K antisense CTCGAGTCACCCGCCCTTCTGCTC (HisHA-TbSUMOT106K
variant).
Amplification products were first cloned into pGEM-T Easy vector (Promega, Madison,
WI, USA). To generate the construct to express TbSUMO/TbSUMO variants and TbE2
(pCDFDuet-1-TbSUMO-TbE2), the NdeI/ XhoI fragment of TbSUMO was cloned into the
multicloning site 2 (MCS2) of the expression vector pCDFDuet-1 (Novagen, Palo Alto, CA,
USA). Subsequently, the BamHI/ NotI fragment of TbE2 was cloned into multicloning site 1
(MCS1) of the vector. To generate the construct to express TbE1a and TbE1b (pACYCDuet-1-
TbE1a-TbE1b), the NdeI/ XhoI fragment of TbE1b was cloned into the MCS2 of the expression
vector pACYCDuet-1 (Novagen). Subsequently, the EcoRI/ HindIII fragment of TbE1a was
cloned into the MCS1 of the vector.
To construct the plasmid for substrate expression, the ORF of Saccharomyces cerevisiae pro-
liferating cell nuclear antigen (ScPCNA) (P15873.1) was amplified by PCR from S.cerevisiae
genomic DNA using as sense primer CCATGGTAGAAGCAAAATTTG and as antisense
primer CCATGGATTCTTCGTCATTA. ScPCNA ORF was first cloned into pGEM-T Easy
vector (Promega) and then into pBAD-3xFlag vector through BamHI/ HindIII restriction sites.
Then, the NcoI digested fragment was finally cloned into the expression vector pET28a (Nova-
gen) to express C-terminal 3xFlag ScPCNA (pET28a-ScPCNA). To generate ScPCNA SUMOy-
lation mutants (ScPCNAK127R and ScPCNAK164R) the following primers were used to
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amplify by PCR different fragments from ScPCNAORF in pGEM-T Easy vector: ScPCNAK127R
sense GATGCTGATTTCTTAAAGATTGAAGAATTACA, ScPCNAK127R antisense TGTAA
TTCTTCAATGCGTAAGAAATCAGCATC, ScPCNAK164R sense AATATCATGATCACC
AAAGAAACAATAAAGTTTG and ScPCNAK164R antisense CAAACTTTATTGTTTCACG
GGTGATCATGATATT. The final amplification products were cloned into pGEM-T Easy vec-
tor (Promega) and sequenced to confirm the presence of the mutated codon (Macrogen). These
constructions were then cloned into the expression vector pET28a-3xFlag to express C-terminal
3xFlag fusion proteins throughNcoI restriction sites. The same strategy was used to express
TbPCNA-3xFlag (pET28a-TbPCNA).
For TbSENP (Tb927.9.2220) expression the complete ORF was amplified by PCR using
CCCGGGTATGGCAGATATCCTTTTAAATGCCG as sense primer and ACTAGTCGCCT
TCGTGTATAAGGCCAGT as antisense primer and cloned into pGEM-T Easy vector (Pro-
mega) and then into pBAD-GST vector through SmaI/ SpeI restriction sites.
For His-HA-TbSUMO-GST expression the complete ORF of TbSUMO was amplified by
PCR using CCATGGACGAACACCACCAC as sense primer, ACTAGTCGCCATGCACCA
AAGACACCCGCCTGTCTGCTCC as antisense primer and a plasmid construction with
the complete ORF of HisHA-TbSUMO as template. The amplified fragment was cloned into
pGEM-T Easy vector (Promega) and digested with NcoI and SpeI (New England Biolabs, Ips-
wich, MA, USA) for cloning into pBAD-GST vector.
The identity of the constructions described was confirmed by sequencing (Macrogen).
In vivo reconstituted SUMOylation
Escherichia coli BL21 (DE3) cells were transformed with pCDFDuet-1-TbSUMO/TbSUMO
variants-TbE2 and used for the preparation of Calcium Chloride competent cells. These cells
were transformed with pACYCDuet-1-TbE1a-TbE1b and competent bacteria were made again
to transform with pET28a-ScPCNA, pET28a-ScPCNAK127R, pET28a-ScPCNAK164R or
pET28a-TbPCNA. To assess the SUMOylation reaction cells containing the three plasmids
mentioned (or a subset of them for control experiments) were cultured in Luria–Bertani (LB)
medium at 37°C to an OD600nm of 0.6, and then induced with 1 mM isopropyl β-D-1-thioga-
lactopyranoside (IPTG) for 5 hr at 37°C with vigorous shaking (250 rpm). Cells were harvested
by centrifugation and resuspended in lysis buffer (150 mMNaCl, 50 mM Tris HCl, 0.4 mg/ml
lysozyme, 0.1% Triton X-100, 10 mM ethylene diamine tetraacetic acid (EDTA), 1 mM phenyl-
methylsulfonyl fluoride (PMSF)—pH 7.6) and sonicated when necessary. Samples were then
centrifuged for 30 min at 23000 x g and 70 μl of supernatants were resuspended in Laemmli
sample buffer with 100 mM DTT (7:3) and boiled for 5 min. For deconjugation assays 70 μl of
supernatants were incubated for 2 hr at 28°C with 70 μl of TbSENP supernatant with or with-
out 25 mM N-ethylmaleimide (NEM). Finally samples were resuspended in Laemmli sample
buffer with 100 mMDTT (7:3) and boiled for 5 min. Samples were analyzed by Western blot.
Purification of SUMOylated ScPCNA
Large-scale preparations were performed using 200 ml of induced cultures. To enrich for
SUMOylated ScPCNA, cleared lysates were loaded onto a 1 ml Ni+2-resin (GE Healthcare),
washed with 50 column volumes (CV) of 50 mM Tris-HCl pH 7.6, 150 mMNaCl, 0.1% Tx-
100, 30 mM imidazole and bound proteins were eluted by the addition of 4 CV of the same
buffer containing 500 mM imidazole.
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Electrophoresis and immunoblotting
Proteins were separated by SDS-PAGE (7.5 or 10% acrylamide) followed by Coomassie Blue
staining or transferred to a nitrocellulose Hybond ECL membrane (GE Healthcare, Pittsburgh,
PA) for probing with high-affinity rat monoclonal anti-HA antibodies (Roche, Basel, Switzer-
land) diluted 1: 500, anti-Flag M2 mouse monoclonal antibody (Sigma, Saint Louis, MO, USA)
diluted 1:5000, anti-polyHistidine mouse monoclonal antibody diluted 1:250 (Sigma), anti-
GST mouse monoclonal antibody diluted 1:1000 (Sigma) or anti-TcSUMO rabbit policlonal
antibody diluted 1:500 [18]. Horseradish peroxidase-conjugated goat anti-rat, anti-rabbit or
anti-mouse secondary antibody (Sigma) diluted 1:5000 was detected by chemiluminescence
using SuperSignal West Pico Chemiluminescent Substrate (Pierce, Rockford, IL, USA). Pre-
stained Protein Molecular Weight markers used were from Pierce.
Expression and purification of recombinant proteins
The construct pBAD-TbSENP-GST or pBAD-His-HA-TbSUMO-GST was transformed into
E. coli BL21 Codon Plus (DE3) cells. Exponential phase cultures (OD600nm = 0.6) were induced
with 0.2% m/v arabinose (Sigma) for 3 hr at 37°C with vigorous shaking (250 rpm). Bacteria
were harvested by centrifugation and resuspended in lysis buffer (150 mMNaCl, 50 mM Tris
HCl, 0.4 mg/ml lysozyme, 0.1% Triton X-100, 10 mM EDTA, 1 mM PMSF—pH 7.6) and soni-
cated when necessary. Samples were centrifuged at 23000 x g for 30 min at 4°C to obtain the
bacterial crude extract. DTT was added to a final concentration of 1 mM. The recombinant
TbSENP-GST was purified using a glutathione-agarose resin (GE Healthcare) equilibrated
with lysis buffer. The column was washed with 10 CV of TBS (50 mM Tris-HCl pH 7.6, 150
mMNaCl) and the sample was eluted with 10 mM Tris-HCl pH 8.8 containing 20 mM reduced
glutathione.
The recombinant His-HA-TbSUMO-GST was purified using a Ni+2-resin (GE Healthcare)
equilibrated with lysis buffer, washed with 50 CV of 50 mM Tris-HCl pH 7.6, 150 mMNaCl,
0.1% Tx-100, 30 mM imidazole and bound proteins were eluted by the addition of 4 CV of the
same buffer containing 500 mM imidazole. Eluates were loaded into a PD-10 desalting column
(GE Healthcare) and then proteins were purified using a glutathione-agarose resin (GE Health-
care) equilibrated with TBS. The column was washed with 10 CV of TBS and the sample was
eluted with 10 mM Tris-HCl pH 8.8 containing 20 mM reduced glutathione.
Isopeptidase activity of TbSENP
To obtain purified TbSUMO conjugates to evaluate isopeptidase activity of TbSENP we used
PCF parasites expressing only a His-HA-tag version of TbSUMO (His-HA-TbSUMO cell line)
[39].
About 1.2 x 109 parasites were collected by centrifugation and washed once in PBS supple-
mented with 20 mMNEM. Cells were then resuspended in lysis buffer (6 M Urea, 500 mM
NaCl, 50 mM Tris HCl, 5 mM βmercaptoethanol—pH 7.5) at a concentration of ~ 3 x 106 par-
asites/μl and sonicated up to loss of viscosity. For further purification of TbSUMO conjugates
lysates were cleared by centrifugation for 30 min at 23000 x g. Supernatants, with the addition
of imidazole at a final concentration of 20 mM, were incubated with Ni2+-Sepharose resin
(GE Healthcare), pre-equilibrated in lysis buffer, with stirring at room temperature for 1.5 hrs.
After centrifugation the resin was washed to reduce Urea concentration with buffer 1 (4 M
Urea, 500 mMNaCl, 50 mM Tris HCl, 20 mM Imidazole—pH 7.50), buffer 2 (2 M Urea, 500
mMNaCl, 50 mM Tris HCl, 30 mM Imidazole—pH 7.50) and buffer 3 (500 mMNaCl, 50 mM
Tris HCl, 30 mM Imidazole—pH 7.50). Proteins were eluted with buffer 4 (500 mMNaCl,
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50 mM Tris HCl, 1 M Imidazole—pH 7.50) and stored at—80°C. The presence of TbSUMO
conjugates was confirmed by Western blot using anti-HA antibodies.
To assess the isopeptidase activity of TbSENP, 0.75 μg of the purified recombinant protein
were incubated with 3 μg of purified TbSUMO conjugates for 1 hr at 37°C, in 30 μl of TBS con-
taining 1 mMDTT with or without 20 mM iodoacetamide (IAA). The assay was evaluated by
Western blot using anti-HA antibodies.
Peptidase activity of TbSENP
To assess the peptidase activity of TbSENP, 0.75 μg of the purified recombinant protein was
incubated with 7.5 μg of purified His-HA-TbSUMO-GST for 1 hr at 37°C, in 30 μl of TBS con-
taining 1 mMDTT with or without 20 mMNEM. The assay was evaluated by Western blot
using anti-HA or anti-GST antibodies.
Supporting Information
S1 Fig. Anti-SUMOWestern blot analysis of soluble cell extracts from induced cultures of
E. coli transformed with only one plasmid pACYCDuet-1-TbE1a-TbE1b, pCDFDuet-1-
TbSUMO-TbE2 or both pCDFDuet-1-TbSUMO-TbE2 and pACYCDuet-1-TbE1a-TbE1b.
Both wild-type TbSUMO and the lysine deficient variant TbSUMOK9R were analyzed.
(TIF)
S2 Fig. In-bacteria SUMOylation of ScPCNA. (A) Anti-Flag Western blot analysis of
ScPCNA performed on soluble cell extracts from induced (I) or uniduced (UI) cultures of E.
coli transformed with pET28-ScPCNA-3xFlag alone (lanes 1 and 2) or in the background of an
incomplete (lane 3 and 4, pACYCDuet-1-TbE1a-TbE1b; lane 5 and 6, pCDFDuet-1-TbSUMO-
TbE2) or a complete (lanes 7 and 8, pCDFDuet-1-TbSUMO-TbE2 plus pACYCDuet-1-TbE1a-
TbE1b) SUMOylation system.
(TIF)
S3 Fig. In-bacteria SUMOylation of TbPCNA. (A) Anti-Flag Western blot analysis of
TbPCNA performed on soluble cell extracts from induced cultures of E. coli transformed with
pET28-TbPCNA-3xFlag alone (lane 4) or in the background of an incomplete (lane 1, pACYC-
Duet-1-TbE1a-TbE1b; lane 2, pCDFDuet-1-TbSUMO-TbE2) or a complete (lane 3,
pCDFDuet-1-TbSUMO-TbE2 plus pACYCDuet-1-TbE1a-TbE1b) SUMOylation system.
(TIF)
S4 Fig. TbSENP peptidase activity. SUMO precursor cleavage by TbSENP was evaluated in
vitro using a TbSUMO precursor produced in E. coli tagged at the N-terminus with His-HA
and fused at the C-terminus to the GST protein. After purification on glutathione-agarose
resin 7.5 μg of His-HA-TbSUMO-GST protein was mixed with 0.75 μg of purified recombinant
TbSENP (produced as described in Materials and Methods) in 30 μl of TBS containing 1 mM
DTT in the absence (lane 2) or presence (lane 3) of the general cysteine peptidase inhibitor N-
ethylmaleimide 20 mM final concentration (NEM) and incubated at 37°C for 1 hr. Samples
were analyzed by Western blot using anti-GST monoclonal antibodies. The substrate without
the addition of the protease was run as a control (lane 1) and the amount of peptidase added to
the reaction mixture was also run as a blank (lane 5).
(TIF)
S5 Fig. Identification of SUMO Acceptor Lysines. Illustration of theoretical peptides result-
ing from digestion of SUMOylated targets when using (A)His-HA-TbSUMO or (B)His-HA-
TbSUMOT106K construct. Digestion of the latter leaves a diagnostic diGly tag with a mass of
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114 Da attached to the modified Lys that can be identified by mass spectrometry. (C)Western
blot analysis of ScPCNA bacterial SUMOylation assay using His-HA-TbSUMO or His-HA-
TbSUMOT106K construct revealed identical patterns.
(TIF)
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